240 filings
Page 5 of 12
8-K
vp68j
15 Jan 21
Other Events
4:12pm
424B5
w1gjlqn rxj
15 Jan 21
Prospectus supplement for primary offering
4:10pm
8-K
gej5e53yt4
17 Dec 20
Other Events
9:06am
8-K
r880m5pzekps
11 Dec 20
Other Events
8:16am
424B5
yuenh8
11 Dec 20
Prospectus supplement for primary offering
8:12am
8-K
km6qtj1i2p4cw2xx x5
7 Dec 20
Regulation FD Disclosure
7:50am
8-K
sc7h1q8uw5 jil1
4 Nov 20
Regulation FD Disclosure
9:14am
8-K
ogx9dov 2om8
28 Oct 20
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results
8:03am
8-K
mq0tyxce wn
21 Oct 20
CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell Malignancies
8:58am
S-8
3gdor
27 Jul 20
Registration of securities for employees
4:46pm
8-K
hsr4h9vbwym5nn2
27 Jul 20
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
4:35pm
8-K
68ba7d4z73eawz
2 Jul 20
Crispr Therapeutics Announces Proposed Public Offering of Common Shares
4:27pm
424B5
rnw min6xskc3
1 Jul 20
Prospectus supplement for primary offering
5:12pm
424B5
6dwrqu8l65l n62
29 Jun 20
Prospectus supplement for primary offering
4:24pm
8-K
ld6gnz3j m3gpcwb3105
12 Jun 20
Departure of Directors or Certain Officers
4:28pm
8-K
vef75who
12 Jun 20
Regulation FD Disclosure
6:04am
DEFA14A
thd1lr
15 May 20
Additional proxy soliciting materials
4:30pm
8-K
5g2fcd 446
14 May 20
Regulation FD Disclosure
9:11am